Navigation Links
Baron and Budd is Encouraged by the First Federal Transvaginal Mesh Lawsuit Verdict
Date:9/11/2013

LOS ANGELES (PRWEB) September 11, 2013

Baron and Budd is encouraged by the jury decision in the first transvaginal mesh lawsuit that awarded $2 million to a woman, Donna Cisson, who claimed that the manufacturer, C.R. Bard Inc., did not sufficiently warn her about defects in the product that in turn caused her bleeding and significant pain. Donna Cisson's case is the first bellwether trial of around 20,000 lawsuits consolidated into a Multi-District Litigation in Charleston, West Virginia. (In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2187)

Donna Cisson claims that she had to undergo two revision surgeries to remove the transvaginal mesh device. Finding that Bard did not adequately warn patients about the design defect in its product, the jury awarded $250 million in compensatory damages and $1.75 million in punitive damages.

C.R. Bard Inc.'s transvaginal mesh device, part of its line of Avualta products, was used to treat pelvic organ prolapse, a condition that may involve urinary incontinence or pain. Inserted surgically, the transvaginal mesh device is alleged to have defects including a high risk for infection, erosion and pain. If patients need to remove the device to remedy the pain, they may find that surgeons have a difficult time fully removing the device. Often, multiple costly and painful revision surgeries are needed. (http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm)

"Although we were not involved with Donna Cisson's transvaginal mesh lawsuit, we are encouraged by the jury's decision,” said Russell Budd of Baron and Budd. "Our goal is to help these woman find some justice. Unfortunately, doctors and patients were not aware of the defects involved with the transvaginal mesh device or the complications surgeons would have removing the device later."

Please call the transvaginal mesh lawyers at Baron and Budd at 1.866.844.4556 or email info(at)baronbudd(dot)com if you or someone you know has had suffered from a health problem after receiving transvaginal mesh implantation surgery. To learn more about the transvaginal mesh lawsuit, visit our website here: http://baronandbudd.com/areas-of-practice/pharmaceuticals/transvaginal-mesh-problems/.

Baron and Budd is very involved in pharmaceutical litigation. The firm is currently handling lawsuits for those allegedly injured by GranuFlo, Actos, Lipitor and transvaginal mesh.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11104031.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
4. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
5. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
6. Tanimura & Antle Artisan® Lettuce Featured on Nationally-Syndicated Appetite for Health for National Salad Month, Consumers Encouraged to “Eat More Salad” for their Heart
7. Workplace Weight Loss Incentives Encouraged by Bystrictin
8. Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Encouraged by $55 Million Endo Health Settlement
9. Pay for performance encouraged physicians to follow blood pressure guidelines
10. First targeted nanomedicine to enter human clinical studies
11. First contact: Early intervention key in diagnosis and treatment of serious mental illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... solutions, announces the continuation of its strategic partnership with and platinum sponsorship of ... nations in the safe and effective management of complex spine deformity cases, particularly ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
(Date:4/24/2017)... TX (PRWEB) , ... April 24, 2017 , ... As ... Memorial Museum today to honor the victims of the Holocaust and Nazi persecution, ... ceremonies at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray ... showcase a healthy CAGR during the forecast period ... in the global digital mobile X-Ray devices market, which is ... in 2017, expanding at a CAGR of 7% over the ... $ opportunity of more than US$ 100 Mn in 2017 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
Breaking Medicine Technology: